Global Bioprocess Bags and Containers Market

MARKET SCOPE:

The global Bioprocess Bags and Containers market is projected to grow significantly, registering a CAGR of 12.2% during the forecast period (2024 – 2032).

Specialized vessels known as bioprocess bags and containers play a crucial role in the bioprocessing domain, facilitating the growth, production, and storage of biological materials like cells, tissues, and bio-based products. These containers are meticulously crafted to establish a sterile and controlled environment, ensuring the safety and integrity of the biological process’s integral to biotechnology and pharmaceutical manufacturing. Specifically designed for single-use applications, they minimize the risk of cross-contamination between batches. Constructed from flexible, durable, and biocompatible materials such as polyethylene, polypropylene, or other polymers, these containers offer ease in handling, storage, and transportation. To uphold aseptic conditions during the manufacturing process, bioprocess bags and containers are pre-sterilized, a critical measure in preventing microbial contamination and upholding the final product's quality.

MARKET OVERVIEW:

Driver: Growth in the biological industry is driving the market growth.

The surge in the adoption of single-use technologies is driven by the escalating demand for more efficient, cost-effective, and rapid production of biologics. The active development of personalized medicines and individualized biologics, encompassing patient-specific cellular and gene therapies, as well as therapeutic vaccines, necessitates stringent sterility standards. Consequently, these products are manufactured using single-use equipment and consumables. The unprecedented demand for vaccines during the COVID-19 pandemic has further intensified the utilization of large-scale and laboratory-scale single-use bioreactors, along with associated consumables like bioprocess containers, media bags, filtration assemblies, and other essential consumables. Recent trends reflect a growing number of biologics with higher potency requiring smaller production volumes. Advances in biosimilars targeting niche markets, coupled with ongoing enhancements in production yields and efficiencies, have led to the increased application of single-use technologies such as bioprocess containers and bags, particularly well-suited for small-volume productions. Notably, these technologies are gradually extending their reach into clinical production and commercial operations.

Opportunities: Patent expiry of biologics is expected to pave the way for next generation optical fiber market growth in the upcoming years.

With numerous patented products approaching expiration, companies are facing financial constraints in funding their research and development (R&D) pipelines. According to information presented in the Generics and Biosimilars Initiative Journal, approximately twelve biological products, boasting global sales exceeding USD 67 billion, are anticipated to encounter biosimilar competition by 2020. The expiration of patents for blockbuster drugs has prompted pharmaceutical and biotechnology firms to escalate their R&D expenditures. The patent expiry of biologics has, in turn, led to a surge in R&D efforts for these products and a transition from the developmental stage to commercial production. Given the substantial costs associated with the development and manufacturing of biologics, companies are progressively redirecting their focus toward methods that offer greater cost efficiency compared to traditional biomanufacturing approaches. Consequently, many biopharmaceutical manufacturers are integrating single-use bioprocessing technologies into their development processes. Through the adoption of single-use bioprocessing assemblies like bioprocess containers, biomanufacturing companies can create innovative products within budgetary constraints, meeting the evolving needs and demands of their customers.

COVID IMPACT:

Initially, the onset of the COVID-19 pandemic substantially influenced the bioprocess containers market, with global lockdowns disrupting the supply chain of essential instruments, raw materials, and other crucial products. However, the scenario shifted as research and development activities took center stage for the creation of a COVID-19 vaccine. Substantial investments, both from private and government entities, were directed towards vaccine development, significantly affecting the market due to the indispensable role played by bioprocess containers in the vaccine's development and production. Notably, data published in July 2021, sourced from PubMed, revealed that the Coalition for Epidemic Preparedness Innovations (CEPI) invested USD 5.6 billion in the development of COVID-19 vaccines, accompanied by a noteworthy USD 51.1 billion expenditure on advanced purchase agreements (APAs). Consequently, with such substantial investments, the pandemic ultimately had a considerable positive impact on the studied market.

SEGMENTATION ANALYSIS:

The 2D bioprocess containers segment is anticipated to grow significantly during the forecast period.

The segment of 2D bioprocess containers is poised to capture a notable market share, primarily attributed to their ability to streamline existing biopharmaceutical production processes and their utility in media preparation, fluid management, and product storage. Widely employed for cell harvesting, delivering bulk drug products, and managing bulk drug precursors, 2D bioprocess containers are integral to these processes. As investments in the development and expansion of biologics production continue to rise, the demand for 2D bioprocess containers is expected to surge, consequently driving growth in this segment. Noteworthy companies like Thermo Fisher, CellBios, and Cole-Palmer are among those offering advanced 2D bioprocess containers.

The ongoing trend of increased investments in the development and manufacturing of biologics is compelling manufacturers of bioprocess containers to enhance their product offerings and expand their production capacities. This positive momentum is expected to particularly benefit the 2D bioprocess containers segment. For instance, in February 2022, ALLpaQ Packaging Group unveiled its latest range, the ALLpaQ 500 PLUS Bioprocess Container, signaling a commitment to leading the market and meeting client requirements through strategic investments in bioprocess containers.

The pharmaceutical and biopharmaceutical companies is anticipated to grow significantly during the forecast period.

The bioprocess containers market is categorized based on end users, including pharmaceutical & biopharmaceutical companies, CROs & CMOs, and academic & research institutes. In 2020, the pharmaceutical & biopharmaceutical companies segment dominated the bioprocess containers market, holding the largest share. The escalating demand for biopharmaceuticals, particularly among the elderly population susceptible to various diseases and disorders treatable with biologics, is a significant factor. Consequently, there is a growing emphasis among biopharmaceutical companies on developing cost-effective biologics. The widespread applications of bioprocess containers in research and process development contribute to their increasing adoption, aligning with the expanding landscape of biologics and biosimilars development and manufacturing.

REGIONAL ANALYSIS:

The North American region is set to witness significant growth during the forecast period.

The North American region houses some of the largest pharmaceutical and biopharmaceutical companies actively involved in the development and production of biologics.

The market growth is anticipated to receive a significant boost due to the heightened demand for biopharmaceutical products, driven by the substantial burden of chronic diseases and government initiatives. For example, in May 2021, Quebec became the fourth Canadian province to implement a mandatory biosimilar switching program. This policy shift, with certain exceptions, entails allowing only biosimilars on lists of approved biologics, if available. Such initiatives are expected to encourage the adoption of biologics, consequently exerting a profoundly positive impact on the bioprocess containers market and fostering its growth.

In the North American region, the United States is poised to command a substantial market share in the bioprocess containers market. This is attributed to the considerable investment in biologics, a high number of biologics approvals in the country, and the escalating burden of chronic diseases. For instance, in July 2021, Cytiva and Pall Corporation announced plans to invest approximately USD 1.5 billion over two years to enhance their capacity in response to the growing demand for biotechnology products.

COMPETITIVE ANALYSIS

The global Bioprocess Bags and Containers market is reasonably competitive with mergers, acquisitions, and product launches. See some of the major key players in the market.

Avantor, Inc.

• In June 2021, Avantor, Inc. (US) completed the acquisition of RIM Bio, a prominent Chinese manufacturer specializing in single-use bioprocess bags and assemblies designed for applications in biopharmaceutical manufacturing. Through this strategic acquisition, Avantor significantly expanded its presence and capabilities in bioproduction within the Chinese market.

Sartorius Stedim Biotech

• In April 2021, Sartorius Stedim Biotech (France) inaugurated a new Customer Interaction Center (CIC) in Beijing, China, aiming to enhance its footprint in the country and address the escalating demand within the expanding biopharmaceuticals market.

Sartorius AG

Thermo Fisher Scientific, Inc.

Danaher Corporation

Merck KGaA

Corning Incorporated

Saint-Gobain

Parker Hannifin Corporation

Entegris, Inc.

Meissner Filtration Products, Inc.

Lonza AG

Flexbiosys Inc.

ABEC, Inc.

Cellexus

Scope of the Report

By Type

2D Bioprocess Bags and Containers

3D Bioprocess Bags and Containers

Others

By Application

Upstream Processes

Downstream Processes

Process Development

Others

By End User

Pharmaceutical and Biopharmaceutical Companies

CRO and CMO

Academic and Research Institutes

By Region

North America (the United States & Canada)

Europe (Germany, UK, France, Spain, Italy, and the Rest of Europe)

Asia Pacific (China, Japan, India, and Rest of Asia Pacific)

Rest of the World (the Middle East & Africa, Latin America, and Rest of The World)

Keys reasons to purchasing this report

It provides a technological development map over time to understand the industry’s growth rate and indicates how the Bioprocess Bags and Containers market is evolving.

The report offers a dynamic method to various factors that drive or restrain the growth of the market and specifies which Bioprocess Bags and Containers submarket will be the main driver of the overall market from 2024 to 2032.

It renders a definite analysis of changing competitive dynamics and stipulates the leading players and what are their prospects over the forecast period.

It builds a nine-year estimate based on how the market is predicted to grow and shows what will market shares of the global region change by 2032 and which country will lead the market in 2032.